Literature DB >> 27404880

Are reverse payments and pay-for-delay settlements business as usual or an anticompetitive practice?

Swati Shah1, Matthew A Silva1, Michael J Malloy1.   

Abstract

Mesh:

Year:  2016        PMID: 27404880     DOI: 10.1038/nbt.3627

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  "Pay for delay" settlements of disputes over pharmaceutical patents.

Authors:  Aaron S Kesselheim; Lindsey Murtagh; Michelle M Mello
Journal:  N Engl J Med       Date:  2011-09-14       Impact factor: 91.245

2.  A shift on "pay for delay"--reopening doors for pharmaceutical competition?

Authors:  Erica J Hemphill Kraus
Journal:  N Engl J Med       Date:  2012-11-01       Impact factor: 91.245

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.